An advisory panel consisting of experts in the fields of toxicology, risk assessment, epidemiology, and pediatric medical and dental specialties began a two day meeting in Washington, D.C. on December 14, 2010, to determine whether the U.S. Food and Drug Administration should reclassify dental amalgam, based on risk assessment and clinical data that demonstrated dental amalgam as a dangerous filling material; carrying a class III medical device classification. A class III medical device is classified as such, because there is insufficient information available regarding the effectiveness and safety of the device solely through the general or special controls sufficient for Class I or Class II devices. Simply put, class III medical devices pose the greatest risk to patients. … Read Full Post